IMLFF - InMed Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.3200
-0.0037 (-1.16%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.3237
Open0.3090
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3090 - 0.3383
52 Week Range0.2170 - 0.8880
Volume183,713
Avg. Volume315,608
Market Cap54.82M
Beta (3Y Monthly)3.10
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga4 months ago

    11 Company Pitches From Benzinga's Cannabis Capital Conference

    Benzinga's Cannabis Capital Conference brought major companies in the space face-to-face with investors in Miami Beach last week. The company is expecting to commence Phase 2 trials of EB treatment within six months. The company boasts a 60-percent reduction in costs for producer clients.

  • We're sorry this is all we were able to find about this topic.